Skip to main content
SpringerLink
Log in

Neue Optionen zur RLS-Therapie

Große Therapiestudien

  • AKTUELLE MEDIZIN
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Opioide sind eine gute Alternative zu Dopaminergika bei schwer behandelbarem Restless-legs-Syndrom (RLS). Und auch Pregabalin könnte für einige der Betroffenen interessant sein: Damit kommt es nur selten zur Augmentation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Trenkwalder C et al. Lancet Neurol 2013; 12:1141–1150.

    Article  CAS  PubMed  Google Scholar 

  2. Pressemitteilung DGN http://www.dgn.org/images/stories/dgn/pdf/2013/131218_PM_DGN_Opiode_bei_RLS_final.pdf

  3. Walters AS. Lancet Neurol. 2012; 12:1128–1129.

    Article  Google Scholar 

  4. Allen RP. N Engl J Med 2014; 370:621–631

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Thomas Müller

Authors
  1. Thomas Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Müller, T. Neue Optionen zur RLS-Therapie. MMW - Fortschritte der Medizin 156, 28 (2014). https://doi.org/10.1007/s15006-014-3256-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-014-3256-7

Search

Navigation